Theratechnologies (TSE:TH) Stock Price Up 29.9% – Should You Buy?

Theratechnologies Inc. (TSE:TH) was up 29.9% during trading on Wednesday . The company traded as high as C$2.99 and last traded at C$2.87. Approximately 168,744 shares changed hands during mid-day trading, an increase of 248% from the average daily volume of 48,537 shares. The stock had previously closed at C$2.21.

Analyst Upgrades and Downgrades

Separately, Research Capitl raised shares of Theratechnologies to a “strong-buy” rating in a research note on Friday, February 14th.

Theratechnologies Price Performance

The stock has a market cap of C$76.89 million, a price-to-earnings ratio of -27.28, a P/E/G ratio of -8.50 and a beta of 1.73. The company has a current ratio of 1.08, a quick ratio of 0.64 and a debt-to-equity ratio of -293.92. The company’s fifty day moving average is C$2.36 and its two-hundred day moving average is C$2.09.

Theratechnologies Company Profile

Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States.